Innoviva, Inc. (INVA) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 5 recommend buying, 4 recommend holding, and 1 recommend selling.
The analyst consensus price target for INVA is $37.67, representing a +55.7% upside from the current price of $24.19. Price targets range from a low of $32.00 to a high of $46.00.
